Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression
Xiaolie He,* Yanjing Zhu,* Mei Wang, Guoxin Jing, Rongrong Zhu, Shilong Wang Research Center for Translational Medicine at East Hospital, School of Life Science and Technology, Tongji University, Shanghai, People’s Republic of China *These authors contributed e...
Guardado en:
Autores principales: | , , , , , |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2016
|
Materias: | |
Acceso en línea: | https://doaj.org/article/a79a205a4dfd47598ba30a199142cb51 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
id |
oai:doaj.org-article:a79a205a4dfd47598ba30a199142cb51 |
---|---|
record_format |
dspace |
spelling |
oai:doaj.org-article:a79a205a4dfd47598ba30a199142cb512021-12-02T02:48:58ZAntidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression1178-2013https://doaj.org/article/a79a205a4dfd47598ba30a199142cb512016-10-01T00:00:00Zhttps://www.dovepress.com/antidepressant-effects-of-curcumin-and-hu-211-coencapsulated-solid-lip-peer-reviewed-article-IJNhttps://doaj.org/toc/1178-2013Xiaolie He,* Yanjing Zhu,* Mei Wang, Guoxin Jing, Rongrong Zhu, Shilong Wang Research Center for Translational Medicine at East Hospital, School of Life Science and Technology, Tongji University, Shanghai, People’s Republic of China *These authors contributed equally to this work Abstract: Major depression is a complex neuropsychiatric disorder with few treatment approaches. The use of nontargeted antidepressants induced many side effects with their low efficacy. A more precise targeting strategy is to develop nanotechnology-based drug delivery systems; hence, we employed solid lipid nanoparticles (SLNs) to encapsulate HU-211 and curcumin (Cur). The antidepressant effects of the dual-drug nanoparticles (Cur/SLNs-HU-211) for major depression treatment were investigated in corticosterone-induced cellular and animal models of major depression. Cur/SLNs-HU-211 can effectively protect PC12 cells from corticosterone-induced apoptosis and can release more dopamine, which may be associated with the higher uptake of Cur/SLNs-HU-211 shown by cellular uptake behavior analysis. Additionally, Cur/SLNs-HU-211 significantly reduced the immobility time in forced swim test, enhanced fall latency in rotarod test, and improved the level of dopamine in mice blood. Cur/SLNs-HU-211 can deliver more Cur to the brain and thus produce a significant increase in neurotransmitters level in brain tissue, especially in the hippocampus and striatum. The results of Western blot and immunofluorescence revealed that Cur/SLNs-HU-211 can significantly enhance the expression of CB1, p-MEK1, and p-ERK1/2. Our study suggests that Cur/SLNs-HU-211 may have great potential for major depression treatment. Keywords: major depression, curcumin, HU-211, solid lipid nanoparticles, dopamineHe XLZhu YJWang MJing GXZhu RRWang SLDove Medical PressarticleMajor depressionCurcuminHU-211Solid Lipid NanoparticlesDopamineMedicine (General)R5-920ENInternational Journal of Nanomedicine, Vol Volume 11, Pp 4975-4990 (2016) |
institution |
DOAJ |
collection |
DOAJ |
language |
EN |
topic |
Major depression Curcumin HU-211 Solid Lipid Nanoparticles Dopamine Medicine (General) R5-920 |
spellingShingle |
Major depression Curcumin HU-211 Solid Lipid Nanoparticles Dopamine Medicine (General) R5-920 He XL Zhu YJ Wang M Jing GX Zhu RR Wang SL Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression |
description |
Xiaolie He,* Yanjing Zhu,* Mei Wang, Guoxin Jing, Rongrong Zhu, Shilong Wang Research Center for Translational Medicine at East Hospital, School of Life Science and Technology, Tongji University, Shanghai, People’s Republic of China *These authors contributed equally to this work Abstract: Major depression is a complex neuropsychiatric disorder with few treatment approaches. The use of nontargeted antidepressants induced many side effects with their low efficacy. A more precise targeting strategy is to develop nanotechnology-based drug delivery systems; hence, we employed solid lipid nanoparticles (SLNs) to encapsulate HU-211 and curcumin (Cur). The antidepressant effects of the dual-drug nanoparticles (Cur/SLNs-HU-211) for major depression treatment were investigated in corticosterone-induced cellular and animal models of major depression. Cur/SLNs-HU-211 can effectively protect PC12 cells from corticosterone-induced apoptosis and can release more dopamine, which may be associated with the higher uptake of Cur/SLNs-HU-211 shown by cellular uptake behavior analysis. Additionally, Cur/SLNs-HU-211 significantly reduced the immobility time in forced swim test, enhanced fall latency in rotarod test, and improved the level of dopamine in mice blood. Cur/SLNs-HU-211 can deliver more Cur to the brain and thus produce a significant increase in neurotransmitters level in brain tissue, especially in the hippocampus and striatum. The results of Western blot and immunofluorescence revealed that Cur/SLNs-HU-211 can significantly enhance the expression of CB1, p-MEK1, and p-ERK1/2. Our study suggests that Cur/SLNs-HU-211 may have great potential for major depression treatment. Keywords: major depression, curcumin, HU-211, solid lipid nanoparticles, dopamine |
format |
article |
author |
He XL Zhu YJ Wang M Jing GX Zhu RR Wang SL |
author_facet |
He XL Zhu YJ Wang M Jing GX Zhu RR Wang SL |
author_sort |
He XL |
title |
Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression |
title_short |
Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression |
title_full |
Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression |
title_fullStr |
Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression |
title_full_unstemmed |
Antidepressant effects of curcumin and HU-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression |
title_sort |
antidepressant effects of curcumin and hu-211 coencapsulated solid lipid nanoparticles against corticosterone-induced cellular and animal models of major depression |
publisher |
Dove Medical Press |
publishDate |
2016 |
url |
https://doaj.org/article/a79a205a4dfd47598ba30a199142cb51 |
work_keys_str_mv |
AT hexl antidepressanteffectsofcurcuminandhu211coencapsulatedsolidlipidnanoparticlesagainstcorticosteroneinducedcellularandanimalmodelsofmajordepression AT zhuyj antidepressanteffectsofcurcuminandhu211coencapsulatedsolidlipidnanoparticlesagainstcorticosteroneinducedcellularandanimalmodelsofmajordepression AT wangm antidepressanteffectsofcurcuminandhu211coencapsulatedsolidlipidnanoparticlesagainstcorticosteroneinducedcellularandanimalmodelsofmajordepression AT jinggx antidepressanteffectsofcurcuminandhu211coencapsulatedsolidlipidnanoparticlesagainstcorticosteroneinducedcellularandanimalmodelsofmajordepression AT zhurr antidepressanteffectsofcurcuminandhu211coencapsulatedsolidlipidnanoparticlesagainstcorticosteroneinducedcellularandanimalmodelsofmajordepression AT wangsl antidepressanteffectsofcurcuminandhu211coencapsulatedsolidlipidnanoparticlesagainstcorticosteroneinducedcellularandanimalmodelsofmajordepression |
_version_ |
1718402116280647680 |